Please login to the form below

Not currently logged in
Email:
Password:

hepatitis C

This page shows the latest hepatitis C news and features for those working in and with pharma, biotech and healthcare.

Gilead targets hep B in half a billion dollar deal with Precision BioSciences

Gilead targets hep B in half a billion dollar deal with Precision BioSciences

Following its success in curing hepatitis C with therapies such as Sovaldi and Harvoni, Gilead is now enlisting a new partner in the fight against hepatitis B (HBV). ... Gilead needs to find new drugs to replace the revenue lost from its hepatitis C

Latest news

More from news
Approximately 104 fully matching, plus 272 partially matching documents found.

Latest Intelligence

  • The race for an HIV ‘cure’ The race for an HIV ‘cure’

    Most of our medicines in Europe are available at the same time, at generic prices, in Africa – in hepatitis C, the drugs are available earlier in Africa than Europe because of

  • The NHS and ABPI at 70: inching closer to the triple win The NHS and ABPI at 70: inching closer to the triple win

    Meanwhile, the pharma industry is hitting new heights in drug innovation, including cures for diseases such as hepatitis C, haemophilia and huge progress in cancer and cell and gene therapy - but

  • Uncertainty, austerity and Brexit Uncertainty, austerity and Brexit

    on hepatitis C treatments and the recent introduction of the Budget Impact Test.

  • No incentive for a cure No incentive for a cure

    Hepatitis C virus treatments like Maviret from AbbVie, which cures people with hard-to-treat genotype 3 after an 8. ... This is the route the NHS in the UK has taken with innovative hepatitis C treatments; it will only pay for the medication if a patient

  • IQVIA: The High IQ Approach of Human Data Science IQVIA: The High IQ Approach of Human Data Science

    Therapeutic advances during that same period have been remarkable; who would have thought we’d find a cure for hepatitis C, or see immunotherapy transform outcomes in cancer care?

More from intelligence
Approximately 3 fully matching, plus 35 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest from PMHub

  • Hanson Zandi

    BPH. Cardiovascular. Consumer health and nutrition. Contraception. Dermatology. Diabetes. GORD. Hepatitis C.

  • Access and elimination: the future of DAAs in hepatitis C

    Access and elimination: the future of DAAs in hepatitis C. Published in Pharmaphorum January 2017. ... The arrival of interferon-free, orally administered direct-acting antivirals (DAAs) in 2014 was a leap forward for the treatment of hepatitis C (HCV),

  • Breaking Down the Barriers to Effective Treatment of Hepatitis C in Latin America

    Breaking Down the Barriers to Effective Treatment of Hepatitis C in Latin America. ... If left untreated, hepatitis C leads to chronic health problems putting a huge strain on national healthcare resources.

  • 90TEN nominated for five Communiqué Awards

    The agency’ s Hepatitis C medical education programme for AbbVie, ‘ Revealing a New Face of Cure’, has been shortlisted for Excellence in Communications via a Live Event or Stand Alone Activity.

  • Atlantis Healthcare

    haemophilia. hepatitis C. incontinence. multiple sclerosis. osteoporosis . rheumatoid arthritis. Additionally, Atlantis has delivered many programmes to support rare diseases, health screening and blood donor management.

More from PMHub
Approximately 4 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics